🔎 Trials Near Me

Beranda › Penyakit Alzheimer › California › Los Angeles

Uji klinis Penyakit Alzheimer di Los Angeles, CA

14 studi untuk Penyakit Alzheimer mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of LY3439539 in Participants With Alzheimer's Disease

Menerima pesertaFase 1
  • Inglewood Clinical, Los Angeles
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Menerima pesertaFase 3
  • USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Menerima pesertaFase 3
  • Inglewood Clinicals, Los Angeles
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Menerima pesertaFase 3
  • Inglewood Clinical, Los Angeles
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06976203

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Menerima pesertaFase 1/2
  • UCLA TMS Clinical and Research Service, Los Angeles
Usia 55 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06597942

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Menerima pesertaFase 2
  • Inglewood Clinical ( Site 1062), Los Angeles
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07033494

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Menerima pesertaFase 3
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Menerima pesertaFase 2/3Sukarelawan sehat diterima
  • University of Southern Califonria, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Menerima pesertaFase 2/3Sukarelawan sehat diterima
  • University of Southern Califonria, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT06647498

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Menerima pesertaFase 2
  • University of California at Los Angeles, Los Angeles
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT07094516

Polyphenols and Cognitive Decline

Menerima pesertaSukarelawan sehat diterima
  • University of California, Los Angeles, Los Angeles
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT06507254

[18F]PI-2620 Phase 3 Histopathological Study

Menerima pesertaFase 3
  • UC Los Angeles, Los Angeles
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT05641688

Cardiac-Control Affecting Learning Through Mindfulness (CALM)

Menerima pesertaSukarelawan sehat diterima
  • University of Southern California, Los Angeles
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT06410157

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Menerima peserta
  • CSMC, Los Angeles
Usia 55 hingga 89 · Semua jenis kelamin · Diperbarui 19 Nov 2025 · NCT07224607

Uji klinis Penyakit Alzheimer di kota lain

Studi lain di Los Angeles

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.